Omron (OTCMKTS:OMRNY) Downgraded to Strong Sell Rating by Zacks Research

Zacks Research lowered shares of Omron (OTCMKTS:OMRNY) from a hold rating to a strong sell rating in a research note published on Thursday,Zacks.com reports.

Omron Price Performance

Shares of OTCMKTS OMRNY opened at $34.52 on Thursday. The stock has a market capitalization of $6.79 billion, a price-to-earnings ratio of 36.34, a PEG ratio of 0.44 and a beta of 1.15. The business has a 50-day moving average of $34.18 and a 200-day moving average of $29.93. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.11 and a quick ratio of 1.37. Omron has a fifty-two week low of $23.23 and a fifty-two week high of $40.76.

Hedge Funds Weigh In On Omron

An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC increased its holdings in shares of Omron Corp. (OTCMKTS:OMRNY) by 50.7% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 2,129 shares of the company’s stock after purchasing an additional 716 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $54,000 as of its most recent filing with the SEC. 1.09% of the stock is owned by institutional investors and hedge funds.

Omron Company Profile

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.